Confidential mandate
Medical-Equipment Treasury and Forecast-Risk Consultant
Planned Hiring / New
Medical-Equipment Treasury and Forecast-Risk Consultant mandate in Chennai, India · Medical Equipment
Medical-equipment finance requires a unified exposure and forecast-risk package connecting imports, commissioning and collection; this four-month project delivers tested decision tools and treasury controls without managing dealing or routine finance operations.
The mandate
The problem is a fragmented view of financial exposure: procurement tracks import commitments, treasury tracks contracted currency and planning forecasts receipts, but the three do not reconcile into a decision-ready cash risk view. The assignment will deliver an Equipment Exposure and Forecast-Risk Package, showing when the same commercial delay changes inventory, foreign-exchange coverage and liquidity at once.
Starting on 19 October 2026, the consultant works three days weekly for four months. Chennai sessions establish data and judgement ownership, with remote model construction between workshops. The package includes a commitment-to-settlement register, scenario model, forecast confidence rules and an approved treasury-control checklist. It is a bounded analytical engagement rather than a fractional treasury seat.
By 18 November 2026, milestone one provides a reconciled exposure baseline and an agreed definition of forecast receipts and committed imports. Milestone two, due 18 January 2027, is a tested cash and currency model with commissioning-delay, collection and purchase-timing scenarios. On 18 February 2027, milestone three delivers a live planning-cycle pilot, policy-owner sign-off and retained-user replay. The final month validates use rather than concealing implementation within an earlier modelling milestone.
The finance director and treasury policy owner accept the outputs jointly. Acceptance requires commitment records to reconcile to finance and procurement sources, currency amounts and maturities to agree with authorised treasury records, and scenario changes to be reproducible by retained analysts. Differences must either be corrected or explicitly accepted with named owners. The model must show exposure separately from the management decision to hedge it.
The sponsor supplies purchase schedules, contract terms, hedge records, collection history and a planning analyst for the pilot. No trading execution, new banking facility, investment product selection or tax opinion is included. Additional entities or a dealing-system integration must pass scope and fee approval. The project closes when the baseline, decision model and control transfer are accepted, not when an exchange-rate forecast proves right.
What you will own
- Reconcile purchase commitments, booked liabilities and settlement forecasts into a single exposure inventory with source ownership, timing assumptions and documented reconciling differences.
- Classify expected receipts by commissioning status, entitlement evidence and collection history so cash scenarios identify assumptions requiring explicit confirmation rather than relying on pipeline percentages.
- Build currency and maturity views that reveal over-coverage, uncovered commitments and timing mismatches without prescribing speculative positions or confusing commercial risk with an optional market view.
- Run commissioning-delay and procurement-rescheduling scenarios through inventory, hedge maturity and liquidity consequences, distinguishing actions that reduce exposure from those that merely change its timing.
- Draft control checks for exposure changes, authorised instruments and model version approval, referring policy decisions to the treasury owner with quantified impacts and approval dependencies.
- Pilot the package in an actual forecast meeting and transfer the refresh procedure with a witnessed analyst reproduction test using a previously unrehearsed assumption change.
Candidate qualifications
- Demonstrate senior finance experience of eighteen years or more with hands-on treasury and planning exposure in imported medical equipment or similar manufacturing. Show a case where procurement timing and customer commissioning created a currency or liquidity problem, and identify the evidence and decision tool you personally produced to resolve it.
- Bring a finance qualification and demonstrable foreign-exchange control knowledge. Explain how you distinguish an accounting balance, a committed exposure and a forecast transaction, with the treatment of maturity changes. Training certificates support but do not replace examples of approved-policy decisions and reconciliation to actual dealing records.
- Show substantial FP&A modelling capability linking revenue assumptions, inventory movement and cash timing. Present a scenario that management initially regarded as unlikely but that materially changed a funding or hedge decision. Explain the sensitivity logic, validation against source records and the limitation you made visible rather than fitting the desired answer.
- Prove delivery of usable treasury or planning artifacts under a fixed-fee scope. Evidence should include baseline acceptance, controlled versions, retained-user training and a case where you managed late data without invoicing an untested deliverable. The role does not require authority to transact; candidates must respect independent policy ownership and protect sensitive bank and customer records.
Application
Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.
There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 12 October 2026. Mandate reference PCT-CON-2026-IND-42.
More seats like this one
This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.